Senior Principal Scientist, Oncology Translational Science and Clinical Biomarkers jobs in United States
cer-icon
Apply on Employer Site
company-logo

Merck · 4 days ago

Senior Principal Scientist, Oncology Translational Science and Clinical Biomarkers

Merck is a leading global healthcare company dedicated to delivering breakthrough innovations that improve the lives of cancer patients worldwide. The Senior Principal Scientist will drive translational research and clinical biomarker development for oncology programs, collaborating with cross-functional teams to formulate strategies and ensure the successful implementation of clinical biomarker plans.

BiotechnologyHealth CareMedicalPharmaceutical
check
Comp. & Benefits
badNo H1Bnote

Responsibilities

Identify asset-specific translational deliverables & gaps. Building testable hypothesis & forming BMx strategy: collaborate across different LFs, to formulate testable clinical and translational hypotheses; and develop clinical biomarker and translational research strategy to test the hypothesis
Alignment, risk mitigation & strategy implementation: align with asset development team strategy. Build critical scientific insight to identify gaps and risks, pro-actively develop mitigation plans. Work with matrixed stakeholders to ensure implementation
Collaborate with Asset Development Teams, Early Development Teams; Product Development Teams, Clinical Trial Teams, Discovery, Informatics; Diagnostics, quantitative modeling team; Biostats, Molecular Assay teams, and other key LFs to author protocol-specific biomarker plans and ensure their efficient implementation
Incorporate cutting edge scientific and technical advances to support clinical developments. Proactively identify and engage external KOL’s on specific hypothesis-driven collaborations to complement internal effort. Drive the publication of biomarker and translational research for respective studies
Analysis, interpretation & impact: collaborate with forementioned line functions to build formal analysis plans, participate in data analysis and interpretation. Effectively communicate the study plan, update and output across different function areas to for optimal impact on projects
Contribute to Health Authority engagements; Registrational Effort and Post Marketing Commitments
Hypothesis-building & strategy forming: collaborate with stakeholders in clinical development team(s), to formulate testable clinical hypothesis and develop clinical biomarker and translational research strategy to test the hypothesis
Alignment, risk mitigation & strategy implementation: align the development team strategy with broader portfolio strategy. Build critical scientific insight to identify gaps and risks, pro-actively develop mitigation plans. Work with matrixed stakeholders to ensure implementation
Analysis, interpretation & impact: collaborate with line function experts to build formal analysis plans, participate in data analysis and interpretation. Effectively communicate the study plan, update and output across different function areas to for optimal impact on projects

Qualification

OncologyTranslational ResearchBiomarker DevelopmentClinical DevelopmentImmuno-OncologyClinical ResearchDiagnostics DevelopmentDrug DevelopmentRisk MitigationStrategy DevelopmentBiomedical ResearchAnalytical SkillsCommunication SkillsInterpersonal Skills

Required

PH.D., M.D. or M.D./Ph.D. with a minimum of 10 years' experience in oncology biomarker studies and translational clinical research
Experience in clinical trial development and execution; clear strategic view on the translational needs in clinical studies; experience & familiarity with experimental and bioinformatic aspects of translational research and biomarker development
Ability to demonstrate a broad understanding of the end-to-end drug and diagnostic development process, and specific expertise in oncology, preferably immuno-oncology
Possess communication and analytical skills to regularly interface with a wide variety of stakeholders within the organization, as well as with external clinicians and scientists
Track record in cross-functional, highly matrixed collaborative groups on drug discovery and/or clinical development
Strong interpersonal skills, as well as the ability to function in a team environment
A proven track record in biomedical research
Demonstrated record of scientific scholarship and achievement

Preferred

Prior drug discovery experience in oncology
Prior experience in communication with health authorities
Specific expertise in immunology and/or immuno-oncology
Experience in companion diagnostics development
Project experience in biomarker discovery, biomarker and diagnostic development, and early or late drug development is desired

Benefits

Medical
Dental
Vision healthcare and other insurance benefits (for employee and family)
Retirement benefits, including 401(k)
Paid holidays
Vacation
Compassionate and sick days

Company

Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.

Funding

Current Stage
Public Company
Total Funding
$5.59M
Key Investors
Private Capital AdvisorsGavi, the Vaccine Alliance
2018-11-25Post Ipo Equity· $0.59M
2016-01-21Series Unknown· $5M
1980-12-19IPO

Leadership Team

leader-logo
Betty Larson
Executive Vice President and Chief Human Resources Officer
linkedin
leader-logo
Dean Li
Executive Vice President and President, Merck Research Laboratories
linkedin
Company data provided by crunchbase